Macquarie Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.95M Buy
19,643
+4,643
+31% +$1.41M 0.01% 947
2025
Q1
$4.97M Hold
15,000
0.01% 982
2024
Q4
$4.63M Hold
15,000
0.01% 962
2024
Q3
$3.18M Sell
15,000
-13,500
-47% -$2.86M ﹤0.01% 1085
2024
Q2
$7.99M Sell
28,500
-30,457
-52% -$8.53M 0.01% 857
2024
Q1
$15.7M Buy
58,957
+30,457
+107% +$8.13M 0.02% 718
2023
Q4
$6.59M Hold
28,500
0.01% 908
2023
Q3
$4.16M Hold
28,500
0.01% 975
2023
Q2
$6.58M Hold
28,500
0.01% 874
2023
Q1
$6.9M Hold
28,500
0.01% 877
2022
Q4
$8.27M Sell
28,500
-849
-3% -$246K 0.01% 874
2022
Q3
$1.92M Sell
29,349
-145
-0.5% -$9.47K ﹤0.01% 1246
2022
Q2
$2.11M Hold
29,494
﹤0.01% 1278
2022
Q1
$2.89K Hold
29,494
﹤0.01% 1270
2021
Q4
$2.5M Hold
29,494
﹤0.01% 1308
2021
Q3
$2.35M Buy
29,494
+743
+3% +$59.3K ﹤0.01% 1332
2021
Q2
$2.8M Hold
28,751
﹤0.01% 1313
2021
Q1
$3.36M Sell
28,751
-69
-0.2% -$8.07K ﹤0.01% 1020
2020
Q4
$3.2M Hold
28,820
﹤0.01% 975
2020
Q3
$3.42M Hold
28,820
0.01% 909
2020
Q2
$3.26M Buy
28,820
+320
+1% +$36.2K 0.01% 887
2020
Q1
$1.9M Hold
28,500
﹤0.01% 923
2019
Q4
$2.6M Hold
28,500
﹤0.01% 963
2019
Q3
$2.46M Hold
28,500
﹤0.01% 971
2019
Q2
$2.99M Sell
28,500
-12,100
-30% -$1.27M 0.01% 911
2019
Q1
$5.09M Buy
40,600
+1,500
+4% +$188K 0.01% 780
2018
Q4
$4.41M Buy
39,100
+6,400
+20% +$721K 0.01% 774
2018
Q3
$7M Buy
32,700
+8,900
+37% +$1.91M 0.01% 714
2018
Q2
$6.66M Buy
+23,800
New +$6.66M 0.01% 715